Medication-Assisted Treatment (MAT) Centers in Alaska

No. Alaska MAT providers do not require criminal-history disclosure to enroll. Federal law (42 CFR Part 2) protects substance-use treatment records; a criminal record will not block admission to a mat program.

Self-pay monthly cost for mat in Alaska typically ranges from $150 to $700, depending on medication, counseling intensity, and whether lab work is included. Long-acting injectables (Sublocade, Vivitrol) billed without insurance can exceed $1,500 per dose. Most patients pay far less through insurance or Alaska Medicaid (DenaliCare).

Alaska Medicaid (DenaliCare) copays for MAT visits are typically $0–$3, and are often waived for patients with behavioral-health conditions. Pharmacy copays for buprenorphine or naltrexone prescriptions follow the same schedule.

Yes. Blue Cross Blue Shield plans in Alaska cover all three FDA-approved MAT medications. BCBS typically requires the provider to be in-network; most major MAT programs in Anchorage and across Alaska accept BCBS.

Yes. mat is a federally approved medication used legally across Alaska. Methadone is dispensed only at SAMHSA-certified Opioid Treatment Programs (OTPs); buprenorphine is prescribed by licensed clinicians; naltrexone has no prescriber waiver requirement. State licensing agencies oversee all MAT programs.

Many Alaska patients stay on mat for a year or more, and some stay indefinitely. Duration depends on individual stability, quality of life, and risk of relapse. Research consistently shows that longer MAT duration is associated with lower overdose mortality.

Use the SAMHSA treatment locator at findtreatment.gov, filter by Alaska, and search for medications offered. You can also browse our directory of MAT programs filtered to Alaska, or call 988 for live referrals from a trained counselor.

Feeling worse shortly after the first buprenorphine dose can indicate precipitated withdrawal (taken too soon after a full agonist). Call your Alaska clinic immediately — the team can adjust timing, switch to micro-induction, or provide supportive medication to relieve symptoms.

During induction (first 1–2 weeks), mild drowsiness is common. Once stabilized, most patients fully resume work, including safety-sensitive jobs such as CDL driving, subject to any employer drug-testing policies. Alaska clinicians can issue letters documenting stability.

Yes. Most Alaska regions have perinatal-addiction programs coordinating OB care, MAT, and social support. Call 988 or SAMHSA 1-800-662-4357 for Alaska-specific referral. Anchorage-area hospitals typically have dedicated perinatal-addiction coordinators.

Yes. Family counseling is a standard component of many Alaska MAT programs; sessions with a partner, parent, or adult child can be scheduled with the patient’s consent. Al-Anon and Nar-Anon groups provide parallel support for family members.

No — not without a narrowly tailored court order (not a standard subpoena). Alaska MAT clinics train staff to reject improper requests. If a warrant is presented, the clinic attorney reviews its scope before any release.